← Leaderboards
Barbara S. Fox
Yale University
$1,122,326
Attributed
$1,122,326
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $213.6K · FY2009–11$250K$187.5K$125K$62.5K$0
'09
'10
'11
Funding mix
By agency
NIH$1,122,326 · 4
By mechanism
U19$638,189 · 1
R43$484,137 · 3
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Erin Longbrake$980,098
- Noah Wolcott Palm$9,118,503
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectInflammatoryColostrumExposed Human PopulationEnzyme Linked Immunosorbent AssayImmunotherapyClinical ResearchCocaineDrug Abuse ChemotherapyDrug Abuse TherapyDrug AddictionDrug Addiction AntagonistAntibodyDrug InteractionsAntibody SpecificityClinical PharmacologyCattleActive ImmunizationDesignCooperative StudyBaseDoseAntibodiesIn Vitro
Grant awards (6)
Oral Antibody Therapy for Celiac Disease$145,306
R43 · FY2011 · DK · contact PI
Oral anti-TNF antibody for inflammatory bowel disease$213,589
R43 · FY2010 · DK · contact PI
Topical Anti-TNF Antibody for Oral Mucositis$125,242
R43 · FY2009 · DE · contact PI
IMMUNOGENICITY OF COCAINE VACCINE IN HUMAN SUBJECTS$171,205
U19 · FY2002 · DA
IMMUNOGENICITY OF COCAINE VACCINE IN HUMAN SUBJECTS$295,779
U19 · FY2000 · DA
IMMUNOGENICITY OF COCAINE VACCINE IN HUMAN SUBJECTS$171,205
U19 · FY2000 · DA